1
|
Pajouheshnia R, Gini R, Gutierrez L, Swertz MA, Hyde E, Sturkenboom M, Arana A, Franzoni C, Ehrenstein V, Roberto G, Gil M, Maciá MA, Schäfer W, Haug U, Thurin NH, Lassalle R, Droz-Perroteau C, Zaccagnino S, Busto MP, Middelkoop B, Gembert K, Sanchez-Saez F, Rodriguez-Bernal C, Sanfélix-Gimeno G, Hurtado I, Acosta MBD, Poblador-Plou B, Carmona-Pírez J, Gimeno-Miguel A, Prados-Torres A, Schultze A, Jansen E, Herings R, Kuiper J, Locatelli I, Jazbar J, Žerovnik Š, Kos M, Smit S, Lind S, Metspalu A, Simou S, Hedenmalm K, Cochino A, Alcini P, Kurz X, Perez-Gutthann S. Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Development and Pilot of a Metadata List and Catalogue in Europe. Pharmacoepidemiol Drug Saf 2024; 33:e5871. [PMID: 39145406 DOI: 10.1002/pds.5871] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2023] [Revised: 05/30/2024] [Accepted: 06/24/2024] [Indexed: 08/16/2024]
Abstract
PURPOSE Metadata for data dIscoverability aNd study rEplicability in obseRVAtional studies (MINERVA), a European Medicines Agency-funded project (EUPAS39322), defined a set of metadata to describe real-world data sources (RWDSs) and piloted metadata collection in a prototype catalogue to assist investigators from data source discoverability through study conduct. METHODS A list of metadata was created from a review of existing metadata catalogues and recommendations, structured interviews, a stakeholder survey, and a technical workshop. The prototype was designed to comply with the FAIR principles (findable, accessible, interoperable, reusable), using MOLGENIS software. Metadata collection was piloted by 15 data access partners (DAPs) from across Europe. RESULTS A total of 442 metadata variables were defined in six domains: institutions (organizations connected to a data source); data banks (data collections sustained by an organization); data sources (collections of linkable data banks covering a common underlying population); studies; networks (of institutions); and common data models (CDMs). A total of 26 institutions were recorded in the prototype. Each DAP populated the metadata of one data source and its selected data banks. The number of data banks varied by data source; the most common data banks were hospital administrative records and pharmacy dispensation records (10 data sources each). Quantitative metadata were successfully extracted from three data sources conforming to different CDMs and entered into the prototype. CONCLUSIONS A metadata list was finalized, a prototype was successfully populated, and a good practice guide was developed. Setting up and maintaining a metadata catalogue on RWDSs will require substantial effort to support discoverability of data sources and reproducibility of studies in Europe.
Collapse
Affiliation(s)
- Romin Pajouheshnia
- Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands
- Department of Epidemiology, RTI Health Solutions, Barcelona, Spain
| | - Rosa Gini
- Agenzia Regionale di Sanità della Toscana, Florence, Italy
| | - Lia Gutierrez
- Department of Epidemiology, RTI Health Solutions, Barcelona, Spain
| | - Morris A Swertz
- Department of Genetics, University Medical Centre Groningen, Groningen, The Netherlands
| | - Eleanor Hyde
- Department of Genetics, University Medical Centre Groningen, Groningen, The Netherlands
| | | | - Alejandro Arana
- Department of Epidemiology, RTI Health Solutions, Barcelona, Spain
| | - Carla Franzoni
- Department of Epidemiology, RTI Health Solutions, Barcelona, Spain
| | - Vera Ehrenstein
- Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
| | | | - Miguel Gil
- Base de datos para la Investigación Farmacoepidemiológica en Atención Primaria, Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain
| | - Miguel Angel Maciá
- Base de datos para la Investigación Farmacoepidemiológica en Atención Primaria, Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain
| | - Wiebke Schäfer
- Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany
| | - Ulrike Haug
- Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany
- Faculty of Human and Health Science, University of Bremen, Bremen, Germany
| | - Nicolas H Thurin
- Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux, Bordeaux, France
| | - Régis Lassalle
- Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux, Bordeaux, France
| | | | - Silvia Zaccagnino
- European Society for Blood & Marrow Transplantation, Leiden, The Netherlands
| | - Maria Paula Busto
- European Society for Blood & Marrow Transplantation, Leiden, The Netherlands
| | - Bas Middelkoop
- European Society for Blood & Marrow Transplantation, Leiden, The Netherlands
| | - Karin Gembert
- Department of Epidemiology, Karolinska Institutet, Stockholm, Sweden
| | - Francisco Sanchez-Saez
- Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain
| | - Clara Rodriguez-Bernal
- Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain
| | - Gabriel Sanfélix-Gimeno
- Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain
| | - Isabel Hurtado
- Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain
| | | | - Beatriz Poblador-Plou
- EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain
| | - Jonás Carmona-Pírez
- EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain
- Technical Advisory Subdirectorate of Information Management (STAGI), Andalusian Health Service (SAS), Seville, Spain
| | - Antonio Gimeno-Miguel
- EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain
| | - Alexandra Prados-Torres
- EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain
| | - Anna Schultze
- London School of Hygiene and Tropical Medicine, London, UK
| | - Ella Jansen
- PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands
| | - Ron Herings
- PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands
| | - Josine Kuiper
- PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands
| | - Igor Locatelli
- Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
| | - Janja Jazbar
- Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
| | - Špela Žerovnik
- Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
| | - Mitja Kos
- Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
| | - Steven Smit
- Institute of Genomics, University of Tartu, Tartu, Estonia
| | - Sirje Lind
- Institute of Genomics, University of Tartu, Tartu, Estonia
| | | | | | | | - Ana Cochino
- European Medicines Agency, Amsterdam, The Netherlands
| | - Paolo Alcini
- European Medicines Agency, Amsterdam, The Netherlands
| | - Xavier Kurz
- European Medicines Agency, Amsterdam, The Netherlands
| | | |
Collapse
|
2
|
Gini R, Pajouheshnia R, Gutierrez L, Swertz MA, Hyde E, Sturkenboom M, Arana A, Franzoni C, Ehrenstein V, Roberto G, Gil M, Maciá MA, Schäfer W, Haug U, Thurin NH, Lassalle R, Droz-Perroteau C, Zaccagnino S, Busto MP, Middelkoop B, Gembert K, Sanchez-Saez F, Rodriguez-Bernal C, Sanfélix-Gimeno G, Hurtado I, Acosta MBD, Poblador-Plou B, Carmona-Pírez J, Gimeno-Miguel A, Prados-Torres A, Schultze A, Jansen E, Herings R, Kuiper J, Locatelli I, Jazbar J, Žerovnik Š, Kos M, Smit S, Lind S, Metspalu A, Simou S, Hedenmalm K, Cochino A, Alcini P, Kurz X, Perez-Gutthann S. Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Lessons Learnt From the MINERVA Project in Europe. Pharmacoepidemiol Drug Saf 2024; 33:e5884. [PMID: 39145403 DOI: 10.1002/pds.5884] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2023] [Revised: 05/30/2024] [Accepted: 07/17/2024] [Indexed: 08/16/2024]
Affiliation(s)
- Rosa Gini
- Agenzia Regionale di Sanità Della Toscana, Florence, Italy
| | - Romin Pajouheshnia
- Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands
- Department of Epidemiology, RTI Health Solutions, Barcelona, Spain
| | - Lia Gutierrez
- Department of Epidemiology, RTI Health Solutions, Barcelona, Spain
| | - Morris A Swertz
- Department of Genetics, University Medical Centre Groningen, Groningen, The Netherlands
| | - Eleanor Hyde
- Department of Genetics, University Medical Centre Groningen, Groningen, The Netherlands
| | - Miriam Sturkenboom
- Department of Datascience and Biostatistics, University Medical Centre Utrecht, Utrecht, The Netherlands
| | - Alejandro Arana
- Department of Epidemiology, RTI Health Solutions, Barcelona, Spain
| | - Carla Franzoni
- Department of Epidemiology, RTI Health Solutions, Barcelona, Spain
| | - Vera Ehrenstein
- Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
| | | | - Miguel Gil
- Base de Datos Para la Investigación Farmacoepidemiológica en Atención Primaria, Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain
| | - Miguel Angel Maciá
- Base de Datos Para la Investigación Farmacoepidemiológica en Atención Primaria, Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain
| | - Wiebke Schäfer
- Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany
| | - Ulrike Haug
- Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany
- Faculty of Human and Health Science, University of Bremen, Bremen, Germany
| | - Nicolas H Thurin
- Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux, Bordeaux, France
| | - Régis Lassalle
- Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux, Bordeaux, France
| | | | - Silvia Zaccagnino
- European Society for Blood & Marrow Transplantation, Leiden, The Netherlands
| | - Maria Paula Busto
- European Society for Blood & Marrow Transplantation, Leiden, The Netherlands
| | - Bas Middelkoop
- European Society for Blood & Marrow Transplantation, Leiden, The Netherlands
| | - Karin Gembert
- Department of Epidemiology, Karolinska Institutet, Stockholm, Sweden
| | - Francisco Sanchez-Saez
- Health Services Research & Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain
| | - Clara Rodriguez-Bernal
- Health Services Research & Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain
| | - Gabriel Sanfélix-Gimeno
- Health Services Research & Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain
| | - Isabel Hurtado
- Health Services Research & Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain
| | | | - Beatriz Poblador-Plou
- EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain
| | - Jonás Carmona-Pírez
- EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain
- Technical Advisory Subdirectorate of Information Management (STAGI), Andalusian Health Service (SAS), Seville, Spain
| | - Antonio Gimeno-Miguel
- EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain
| | - Alexandra Prados-Torres
- EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain
| | - Anna Schultze
- Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
| | - Ella Jansen
- PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands
| | - Ron Herings
- PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands
| | - Josine Kuiper
- PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands
| | - Igor Locatelli
- University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia
| | - Janja Jazbar
- University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia
| | - Špela Žerovnik
- University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia
| | - Mitja Kos
- University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia
| | - Steven Smit
- Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia
| | - Sirje Lind
- Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia
| | - Andres Metspalu
- Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia
| | | | | | - Ana Cochino
- European Medicines Agency, Amsterdam, The Netherlands
| | - Paolo Alcini
- European Medicines Agency, Amsterdam, The Netherlands
| | - Xavier Kurz
- European Medicines Agency, Amsterdam, The Netherlands
| | | |
Collapse
|